[HTML][HTML] LRP6 is a potential biomarker of kidney clear cell carcinoma related to prognosis and immune infiltration
L Lu, Y Lei, Y Li, L Wang - Aging (Albany NY), 2024 - ncbi.nlm.nih.gov
Renal cell carcinoma is the most common and most lethal genitourinary tumor. The causes
of renal clear cell carcinoma are complex and the heterogeneity of the tumor tissue is high …
of renal clear cell carcinoma are complex and the heterogeneity of the tumor tissue is high …
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for …
H Ishihara, K Omae, Y Nemoto, R Ishiyama… - International Journal of …, 2024 - Springer
Background There are few comparative studies on dual immune checkpoint inhibitors
(ICIs)(ie, IO-IO) and combination therapies comprising ICIs plus tyrosine kinase inhibitors …
(ICIs)(ie, IO-IO) and combination therapies comprising ICIs plus tyrosine kinase inhibitors …